Algernon NeuroScience and the Centre for Human Drug : vimars

VANCOUVER, British Columbia, April 24, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT:...

Related Keywords

Canada , Haarlem , Noord Holland , Netherlands , United Kingdom , Vancouver , British Columbia , British , Canadian , Christopherj Moreau , Rick Strassman , Algernon Pharmaceuticals Inc , Constraint Induced Movement Therapy , Algernon Pharmaceuticals , Centre For Human Drug Research , Seyltx Inc , Interdisciplinary Conference On Psychedelic Research , Company Phase , Algernon Neuroscience , Human Drug Research , Interdisciplinary Conference , Psychedelic Research , Katelijne Van , Spirit Molecule , Brain Derived Neurotrophic Factor , Constraint Induced Movement , Stroke Study , Canadian Stock Exchange Agn Cn , Mt , Phase 1 ,